Watch MDLN. Know when insiders buy.
One email the day a filing lands. Free.
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 27 | $7.7B | — | 28.8% | $395M | $139M | — | 0.07 | $715M | $111M | $604M | Aug 5 |
| Q1 2026 · Mar 28 | $7.4B | — | 25.0% | $422M | $239M | — | 0.16 | $412M | $96M | $316M | Aug 5 |
| Q2 2025 · Jun 28 | $6.9B | — | 27.7% | $642M | $329M | — | — | $197M | $110M | $87M | Aug 5 |
| Q1 2025 · Mar 29 | $6.6B | — | 27.5% | $571M | $319M | — | — | $682M | $98M | $584M | Aug 5 |
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $28.4B | 26.4% | $2.2B | $1.2B | 4.1% | -0.01 | $1.7B | $447M | $1.3B | $33M | — |
| FY2025 · to Dec 16 | — | — | — | $1.2B | — | — | — | — | — | — | — |
| FY2024 · to Dec 31 | $25.5B | 27.3% | $2.1B | $1.2B | 4.6% | — | $1.8B | $354M | $1.4B | $20M | — |
| FY2023 · to Dec 31 | $23.2B | 25.3% | $1.3B | $234M | 1.0% | — | $1.7B | $275M | $1.4B | $0 | — |
Every number comes from Medline Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.